Citigroup Maintains Neutral on RXO, Raises Price Target to $24

Benzinga Newsdesk www.benzinga.com Positive 59.5%

Neg 0% Neu 0% Pos 59.5%

Citigroup analyst Ariel Rosa maintains RXO (NYSE:RXO) with a Neutral and raises the price target from $17 to $24.

Comments

No comments yet. Be the first!